Four researchers from the USA Health Mitchell Cancer Institute and the Frederick P. Whiddon College of Medicine at the University of South Alabama recently were awarded grants from the Breast Cancer Research Foundation of Alabama (BCRFA). Presented during an event in Birmingham last December, the a...
This work was supported by a grant from the Institut National Du Cancer INCA (INCA_9269; www.e-cancer.fr), and by grants from the Ligue Contre le Cancer (Conférence de Coordination Interrégionale du Grand Est; https://www.ligue-cancer.net), the Fondation ARC (www.fondation-arc.org),...
Susan G. Komen addresses breast cancer on multiple fronts in order to make the biggest impact against this disease. Join our fight!
supportresearchgrantsandprogramsforthebenefitofthebreastcancercause,neededtodeterminethe Foundation’sdirectionregardingitscorporatesponsorshipprogram.Duetotheslowdownintheeconomic environment,amajorsponsoroftheFoundationhaddecidedtopulltwoproductsfromtheshelf.One ...
Funding/Support: This study was supported by grants from the US Department of Defense Breast Cancer Research Program (grant DAMD 17-02-1-0607) and the National Cancer Institute (grant R01 CA118229). Role of the Sponsors: The funding organizations had no role in the design and conduct of ...
Grants to Help Immigrants Fight Breast CancerByline: Victoria Pierce Daily Herald Staff Writer Language and cultural barriers can put...Pierce, Victoria
Sarah McDonald, cancer survivor and author of The Cancer Channel, discusses her experience battling 2 different unrelated cancers and the value oncology pharmacists could have provided with a greater presence on her care team. Watch FDA Grants Accelerated Approval to Tucatinib Combination for Patients ...
Susan G. Komen addresses breast cancer on multiple fronts in order to make the biggest impact against this disease. Join our fight!
FDA Grants Priority Review to Capivasertib Combination for Locally Advanced, Metastatic Breast Cancer Erin Hunter, Assistant Editor June 12th 2023 Capivasertib combined with fulvestrant doubled progression-free survival in patients with recurrent or progressed advanced stage HR-positive HER2-negative breas...
Dedicated to helping people who face cancer. Learn about cancer research, patient services, early detection, treatment and education at cancer.org.